U.S. Delegation Participates In Commission On Narcotic Drugs

In this post in the State Department’s “DipNote” blog, Alyce Ahn, a foreign affairs officer in the State Department’s Bureau of International Narcotics and Law Enforcement Affairs (INL) Office of Anticrime Programs, writes about the U.S. delegation’s participation last week in the 55th session of the Commission on Narcotic Drugs (CND). She outlines the delegation’s work at the conference, concluding, “We’re already beginning to see operational results from the CND. One country noted that, in response to a resolution, it plans to look into using a life-saving drug that can help prevent deaths from overdose. For its part, the United States looks forward to working with other states, as well as [the U.N. Office on Drugs and Crime (UNODC)], in various joint projects and regional counter-narcotics initiatives addressed in the resolutions” (3/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.